Nao Nishimura
Overview
Explore the profile of Nao Nishimura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Endo S, Nishimura N, Toyoda K, Komohara Y, Carreras J, Yuki H, et al.
Cancer Sci
. 2024 Sep;
115(12):3890-3901.
PMID: 39321027
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of lymphoma, accounting for 30% of non-Hodgkin lymphomas. Although comprehensive analysis of genetic abnormalities has led to the classification of...
2.
Kawano Y, Nishimura N, Yasunaga J
Int J Hematol
. 2024 May;
120(2):212-216.
PMID: 38739302
Serum immunofixation electrophoresis (IFE) is often performed for screening monoclonal proteins (M proteins) in immunoglobulin light-chain amyloidosis (AL amyloidosis). However, the performance of serum IFE for detecting M protein in...
3.
Nozawa H, Tsuboi N, Oi T, Takezawa Y, Osawa I, Nishimura N, et al.
J Pediatr Intensive Care
. 2023 Nov;
12(4):296-302.
PMID: 37970141
From the perspective of the Stewart approach, it is known that expansion of the sodium chloride ion difference (SCD) induces alkalosis. We investigated the role of SCD expansion by furosemide-induced...
4.
Sanda K, Fuji S, Satomi H, Kitamura M, Nishimura N, Tada Y, et al.
Blood Cell Ther
. 2023 Jun;
6(2):49-53.
PMID: 37342356
Patients who have undergone hematopoietic cell transplantation (HCT) are at a higher risk of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection than the general population. Therefore, early vaccination is...
5.
Kato H, Shoji K, Jinguji M, Nishimura N, Nakagawa S, Miyairi I
J Pediatric Infect Dis Soc
. 2023 May;
12(6):372-378.
PMID: 37232442
Background: Several reports have suggested that routine use of anaerobic blood culture bottles together with aerobic bottles may improve blood culture positivity. However, the information is still limited regarding the...
6.
Fukuta T, Tanaka T, Hashimoto T, Isahaya K, Kubo Y, Yamano Y, et al.
Int J Hematol
. 2023 Jan;
117(6):933-940.
PMID: 36705847
Nelarabine is an effective treatment for T-cell acute lymphoblastic leukemia/lymphoma. Myelopathy is a rare but serious adverse event associated with this drug. Three patients who received nelarabine at the National...
7.
Koyama S, Morishima T, Saito M, Ma C, Nishimura N, Aoki K, et al.
Oral Dis
. 2023 Jan;
30(2):307-312.
PMID: 36691715
Background: We investigated the impact of the COVID-19 pandemic on oral cancer (OC), comparing diagnosis and number of pre-operative days in the diagnosis of OC in 2019 (pre-COVID-19) and that...
8.
Miyazaki M, Ishibashi M, Ishihara N, Kitasaka M, Furukawa R, Sakai K, et al.
Gan To Kagaku Ryoho
. 2022 Sep;
49(9):981-983.
PMID: 36156019
Methods: An RT viewer (Climb Medical Systems) was installed into the inhouse hospital information system to provide education regarding radiation treatment planning to medical staff members (dentists and nurses) by...
9.
Ansai H, Masuda H, Nakao H, Nishimura N, Kubota M
Pediatr Int
. 2022 Jul;
64(1):e15226.
PMID: 35831245
Background: The treatment for Kawasaki disease (KD) patients refractory to intravenous immunoglobulin (IVIG) therapy is still controversial, and the efficacy of plasma exchange (PE) and infliximab (IFX) therapy for infantile...
10.
Kubota M, Abe Y, Nishimura N, Nakagawa S, Yoshida N
Brain Dev
. 2022 Jun;
44(9):635-639.
PMID: 35753855
Background: Organ transplantation after brain death (BD) of the donor has been promoted in many countries as an established medical treatment. However, some problems with brain-dead organ transplantation have been...